slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,471
Current window 39,241-39,270
Pages 3,950
Rows per page 30
Component
39,241-39,270 of 118,471
12
Includes PK/PD correlation, IRAK4 levels in PBMC, and skin lesion reduction data.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet2 hits
22
Includes a table of prevalence/incidence for various indications and a diagram of the JAK-STAT signaling pathway.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 2 hits
41
Kymera | Investor Presentation Deck | 41 slidesKymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · Roadmap2 hits
09
Details the dosing schedule (13 days) and specific sampling days for buccal cells, skin, and platelets across three dose levels.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · TractionLoop · Golden Circle2 hits
17
The slide highlights the unique 'Protein replacement' approach of Nomlabofusp compared to other modalities like Mitochondrial Oxidative Stress Modifiers, Gene Expression Regulators, Pathway Modifiers, and Gene Therapy.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet2 hits
23
The slide serves as a credibility-building asset by showcasing a partnership with a key non-profit organization in the rare disease space.Larimar Therapeutics | Investor Presentation Deck | 44 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · Traction2 hits
04
Legend Biotech | Results Presentation Deck | 15 slidesLegend Biotech | Results Presentation Deck | 15 slides · Legend Biotech
Conference presentation Investor relations Beat · Need2 hits
03
Lenovo | Results Presentation Deck | 18 slidesLenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · Setup2 hits
04
Includes corporate branding and date.Lenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · Setup2 hits
01
Limbach Holdings | Investor Presentation Deck | 28 slidesLimbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations 2 hits
05
The slide uses a comparative structure to highlight the margin difference between GCR (12-15%) and ODR (25-28%).Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Beat · Problem2 hits
10
Includes photos of the facility and Lion Electric buses.Lion Electric | Investor Presentation Deck | 30 slides · Lion Electric
Pitch deck Investor relations 2 hits
21
Includes detailed reconciliation table and numbered footnotes explaining adjustments.Lion Electric | Investor Presentation Deck | 30 slides · Lion Electric
Pitch deck Investor relations 2 hits
23
Contains specific operational metrics: 2,232 vehicles in order book, 2,500 annual production capacity, 157 units in order book for products not in production, $60 million value for those units.Lion Electric | Investor Presentation Deck | 30 slides · Lion Electric
Pitch deck Investor relations 2 hits
09
Includes a conditional order for 50 Lion C from Highland Electrics.Lion Electric | Results Presentation Deck | 21 slides · Lion Electric
Conference presentation Investor relations 2 hits
12
The slide highlights specific dollar amounts and timelines for EPA programs and state-level subsidies.Lion Electric | Results Presentation Deck | 21 slides · Lion Electric
Conference presentation Investor relations Loop · Why Now2 hits
20
Contains specific operational data points: 196 vehicles delivered in 2022, 519 in 2021, 2,190 order book as of Nov 6 2023, 2,500 annual production capacity, 157 units worth $60M.Lion Electric | Results Presentation Deck | 21 slides · Lion Electric
Conference presentation Investor relations 2 hits
06
The slide uses a chromosome icon for the lead asset and a fast-forward icon for the pipeline strategy.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction2 hits
32
The slide outlines both regulatory exclusivity (NCE) and patent protection (issued/pending) to establish a competitive moat.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 2 hits
13
The slide details the role of MAIN as an investment adviser and administrator, highlighting fee structures and financial contributions.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 2 hits
24
LMM stands for Lower Middle Market. The slide uses a mix of bulleted lists to present financial performance and portfolio quality.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 2 hits
48
Standard financial disclosure slide explaining adjustments for Distributable Net Investment Income and Net Debt to NAV ratios.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 2 hits
22
Includes a mention of a potential combo test with ColoAlert and a research grant from the German Federal Ministry for Education and Research.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 2 hits
01
Matinas BioPharma | Investor Presentation Deck | 31 slidesMatinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 2 hits
03
The slide uses a process-flow structure to connect the technology platform (LNCs) to a lead asset (MAT2203) and future pipeline expansion.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 2 hits
12
This is a credibility-building slide showcasing academic validation of the company's technology.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
24
The chart shows dose-dependent inhibition; LNC formulations consistently outperform Taxol.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 2 hits
31
The slide uses a mix of checkmarks for completed milestones and circular arrows for pending ones.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 2 hits
06
The slide uses a split-screen layout to contrast growth and operational efficiency strategies.Membership Collective Group | Investor Presentation Deck | 31 slides · Soho House & Co Inc.
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
12
Includes footnotes regarding non-GAAP financial measures and expenses not added back for both periods.Membership Collective Group | Investor Presentation Deck | 31 slides · Soho House & Co Inc.
Pitch deck Investor relations Loop · Quick Win Big Bet2 hits